Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.

PubWeight™: 3.71‹?› | Rank: Top 1%

🔗 View Article (PMC 3870204)

Published in Arch Intern Med on April 28, 2008

Authors

Lawrence J Appel1, Jackson T Wright, Tom Greene, John W Kusek, Julia B Lewis, Xuelei Wang, Michael S Lipkowitz, Keith C Norris, George L Bakris, Mahboob Rahman, Gabriel Contreras, Stephen G Rostand, Joel D Kopple, Francis B Gabbai, Gerald I Schulman, Jennifer J Gassman, Jeanne Charleston, Lawrence Y Agodoa, African American Study of Kidney Disease and Hypertension Collaborative Research Group

Author Affiliations

1: Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins institutions, Johns Hopkins University, Baltimore, MD 21205-2223, USA. lappel@jhmi.edu

Associated clinical trials:

African American Study of Kidney Disease and Hypertension ABPM Pilot Study | NCT00582777

Articles citing this

Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48

Patient awareness of chronic kidney disease: trends and predictors. Arch Intern Med (2008) 3.72

Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int (2009) 3.58

Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Kidney Int (2012) 3.46

Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol (2011) 2.50

A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol (2013) 2.13

Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis. J Am Soc Nephrol (2010) 1.92

Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study. Am J Nephrol (2009) 1.80

The spectrum of MYH9-associated nephropathy. Clin J Am Soc Nephrol (2010) 1.72

Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans. Kidney Int (2010) 1.60

Mineral metabolites and CKD progression in African Americans. J Am Soc Nephrol (2012) 1.41

Renal microvascular dysfunction, hypertension and CKD progression. Curr Opin Nephrol Hypertens (2013) 1.32

Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans. Nephrol Dial Transplant (2011) 1.18

Net endogenous acid production is associated with a faster decline in GFR in African Americans. Kidney Int (2012) 1.14

Reappraisal of the impact of race on survival in patients on dialysis. Am J Kidney Dis (2010) 1.04

Candidate genes for non-diabetic ESRD in African Americans: a genome-wide association study using pooled DNA. Hum Genet (2010) 1.01

High burden and unmet patient needs in chronic kidney disease. Int J Nephrol Renovasc Dis (2012) 1.00

Research Needs to Improve Hypertension Treatment and Control in African Americans. Hypertension (2016) 0.99

Relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKD. Clin J Am Soc Nephrol (2012) 0.97

Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease. J Am Soc Nephrol (2010) 0.92

Epidemiology of hypertensive kidney disease. Nat Rev Nephrol (2010) 0.89

Genetic basis of nondiabetic end-stage renal disease. Semin Nephrol (2010) 0.89

A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease. Hypertension (2012) 0.86

CRP polymorphisms and progression of chronic kidney disease in African Americans. Clin J Am Soc Nephrol (2009) 0.86

Potential effects of MYH9-associated nephropathy on dialysis and kidney transplant outcomes. Semin Dial (2010) 0.85

Hypertension and chronic kidney disease progression: why the suboptimal outcomes? Am J Med (2012) 0.83

Circulating TGF-beta1 as a reliable biomarker for chronic kidney disease progression in the African-American population. Kidney Int (2009) 0.82

Urine Ammonium Predicts Clinical Outcomes in Hypertensive Kidney Disease. J Am Soc Nephrol (2017) 0.81

Hypertension and chronic kidney disease: controversies in pathogenesis and treatment. Minerva Urol Nefrol (2013) 0.81

Abrupt Decline in Kidney Function Before Initiating Hemodialysis and All-Cause Mortality: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2016) 0.80

Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial. Clin J Am Soc Nephrol (2014) 0.80

Temporal profile of the renal transcriptome of HIV-1 transgenic mice during disease progression. PLoS One (2014) 0.79

CRP polymorphisms and chronic kidney disease in the third national health and nutrition examination survey. BMC Med Genet (2011) 0.79

Night blood pressure responses to atenolol and hydrochlorothiazide in black and white patients with essential hypertension. Am J Hypertens (2013) 0.77

APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans. BMC Genet (2015) 0.77

APOL1 and nephropathy progression in populations of African ancestry. Semin Nephrol (2013) 0.77

Identification of modifiable chronic kidney disease risk factors by gender in an African-American metabolic syndrome cohort. Nephrol Nurs J (2010) 0.76

Cystatin C, a novel indicator of renal function, reflects severity of cerebral microbleeds. BMC Neurol (2014) 0.76

Effect of intensive blood pressure control on cardiovascular remodeling in hypertensive patients with nephrosclerosis. Int J Nephrol (2013) 0.76

Should a lower blood pressure goal and albuminuria reduction be mandated to slow hypertensive nephropathy? Curr Hypertens Rep (2008) 0.75

Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate-salt hypertension. FASEB J (2016) 0.75

The Apolipoprotein L1 Gene and Cardiovascular Disease. Methodist Debakey Cardiovasc J (2017) 0.75

RAAS blockade, renal failure, ESRD, and death among African Americans in the AASK Posttrial Cohort Study. Arch Intern Med (2008) 0.75

APOL1 Gene Kidney Risk Variants and Cardiovascular Disease: Getting to the Heart of the Matter. Am J Kidney Dis (2017) 0.75

KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation (2017) 0.75

A Classification Model to Predict the Rate of Decline of Kidney Function. Front Med (Lausanne) (2017) 0.75

Articles cited by this

Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29

The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med (1994) 11.65

Retracted Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet (2003) 7.69

K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis (2004) 6.66

Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med (2006) 6.25

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med (2001) 6.22

Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med (2001) 6.00

Blood pressure and end-stage renal disease in men. N Engl J Med (1996) 5.68

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med (2003) 5.47

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA (2001) 4.75

Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol (2003) 4.28

Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. JAMA (1992) 3.86

Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis (2001) 3.68

Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int (2006) 3.64

The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA (1992) 3.01

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy. Lancet (1998) 2.87

Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med (2001) 2.69

Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Intern Med (2006) 2.56

The rationale and design of the AASK cohort study. J Am Soc Nephrol (2003) 2.34

Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol (2003) 2.21

Renal insufficiency in treated essential hypertension. N Engl J Med (1989) 2.17

Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis (1988) 1.99

Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study. Am J Kidney Dis (2007) 1.50

Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Hypertension (2005) 1.42

Validation of creatinine-based estimates of GFR when evaluating risk factors in longitudinal studies of kidney disease. J Am Soc Nephrol (2006) 1.38

The role of ambulatory blood pressure monitoring in chronic and end-stage renal disease. Kidney Int (2006) 1.26

Renal NF-kappaB activation and TNF-alpha upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol (2006) 1.22

Aldosterone in chronic kidney and cardiac disease. J Am Soc Nephrol (2003) 1.10

Long-term ammonium chloride or sodium bicarbonate treatment in two models of polycystic kidney disease. Exp Nephrol (2001) 1.00

Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients. Diabetes Res Clin Pract (1995) 0.99

Articles by these authors

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28

A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41

Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78

Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81

Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27

A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med (2015) 19.14

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis (2003) 15.00

Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99

A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22

Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med (2008) 11.61

Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med (2008) 11.61

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med (2003) 11.25

In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73

Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect (2005) 10.66

Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation (2010) 9.07

Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93

Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med (2013) 8.74

Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48

Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA (2008) 8.45

Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med (2007) 7.90

Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med (2011) 7.81

The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med (2013) 7.54

Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA (2008) 7.50

FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22

Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03

Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA (2005) 6.89

Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet (2012) 6.69

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) (2002) 6.03

Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00

Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med (2014) 5.93

Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA (2011) 5.86

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA (2003) 5.67

Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med (2009) 5.58

A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med (2013) 5.52

The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45

Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int (2003) 5.37

Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol (2004) 5.29

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25

Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA (2010) 5.06

Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol (2009) 5.02

APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med (2013) 5.00

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology,American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons,and Society for Vascular Medicine. J Am Coll Cardiol (2010) 4.90

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation (2006) 4.61

A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med (2012) 4.59

Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (2002) 4.34

Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis (2009) 4.30

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care (2007) 4.30

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27

Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol (2009) 4.16

Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med (2006) 4.09

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med (2003) 4.08

Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med (2011) 4.08

Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis (2003) 3.90

Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension (2006) 3.89